David Hochman, Orchestra Biomed - Accelerating High-Impact Technologies | LSI USA '24

Orchestra BioMed (Nasdaq: OBIO) is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships with leading medical device companies.

LSI Europe ‘24 is filling fast. Secure your spot today to join Medtech and Healthtech leaders.

September 16-20, 2024 The Ritz-Carlton - Sintra, Portugal Register arrow
lsi logo
Customer Login Contact

Events

Market Intelligence

Explore Media

17011 Beach Blvd, Suite 500
Huntington Beach, CA 92647

714-847-3540

© 2024 Life Science Intelligence, Inc., All Rights Reserved.